Tempest Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 551,587 | $772,222 | 100.00% | 2.14% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 545,000 | $763,000 | 100.00% | 2.11% |
| FMR LLC | 11/13/2024 | 431,932 | $604,705 | 0.00% | 1.67% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 220,067 | $308,120 | 42.68% | 0.85% |
| VANGUARD GROUP INC | 11/13/2024 | 176,193 | $246,670 | 0.00% | 0.68% |
| FIL LTD | 11/13/2024 | 129,579 | $181,411 | 0.00% | 0.50% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 105,600 | $147,840 | 0.00% | 0.41% |
| MORGAN STANLEY | 11/14/2024 | 100,151 | $140,212 | 59.64% | 0.39% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 94,912 | $133,000 | -6.07% | 0.37% |
| FULLCIRCLE WEALTH LLC | 10/29/2024 | 62,000 | $68,200 | 100.00% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 54,700 | $76,580 | 100.00% | 0.21% |
| CITADEL ADVISORS LLC | 11/14/2024 | 54,600 | $76,440 | -32.17% | 0.21% |
| DAVENPORT & CO LLC | 10/24/2024 | 50,000 | $70,000 | 0.00% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 45,259 | $63,363 | 100.00% | 0.18% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 43,204 | $60,486 | -0.12% | 0.17% |
| STATE STREET CORP | 11/14/2024 | 41,492 | $58,089 | 0.00% | 0.16% |
| EMPOWER ADVISORY GROUP, LLC | 11/05/2024 | 35,000 | $49,000 | 100.00% | 0.14% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 11/08/2024 | 32,750 | $45,850 | -19.63% | 0.13% |
| CITADEL ADVISORS LLC | 11/14/2024 | 27,500 | $38,500 | -7.09% | 0.11% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 25,378 | $35,520 | 0.00% | 0.10% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 24,572 | $34,401 | 0.00% | 0.10% |
| XTX TOPCO LTD | 11/14/2024 | 23,989 | $33,585 | 100.00% | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 22,921 | $32,089 | 100.00% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 17,000 | $23,800 | 100.00% | 0.07% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 13,077 | $18,000 | 100.00% | 0.05% |
| GROUND SWELL CAPITAL, LLC | 10/29/2024 | 10,896 | $15,254 | 100.00% | 0.04% |
| MAYTECH GLOBAL INVESTMENTS, LLC | 11/13/2024 | 10,000 | $14,000 | 0.00% | 0.04% |
| UBS GROUP AG | 11/14/2024 | 8,395 | $11,753 | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 6,033 | $8,446 | 40,120.00% | 0.02% |
| PARALLEL ADVISORS, LLC | 11/13/2024 | 235 | $330 | -0.42% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/13/2024 | 133 | $186 | 0.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Tempest Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Tempest Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 551,587
Altium Capital Management LP: 545,000
FMR LLC: 431,932
GEODE CAPITAL MANAGEMENT, LLC: 220,067
VANGUARD GROUP INC: 176,193
FIL Ltd: 129,579
10.97% of Tempest Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.36 M shares in the last 24 months. This purchase volume represents approximately $2.89 M in transactions.